TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Global Pharma Consulting (GPC) AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
820
|
586
|
846 |
| Financial expenses |
10
|
2
|
0 |
| Earnings before taxes |
-10
|
-336
|
-122 |
| EBITDA |
-1
|
-334
|
-122 |
| Total assets |
577
|
456
|
716 |
| Current assets |
577
|
456
|
716 |
| Current liabilities |
530
|
402
|
587 |
| Equity capital |
48
|
54
|
129 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.3%
|
11.8%
|
18.0% |
| Turnover per employee |
820
|
586
|
846 |
| Profit as a percentage of turnover |
-1.2%
|
-57.3%
|
-14.4% |
| Return on assets (ROA) |
0%
|
-73.2%
|
-17.0% |
| Current ratio |
108.9%
|
113.4%
|
122.0% |
| Return on equity (ROE) |
-20.8%
|
-622.2%
|
-94.6% |
| Change turnover |
191
|
-235
|
-1,089 |
| Change turnover % |
30%
|
-29%
|
-56% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.